SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-15-005411
Filing Date
2015-07-01
Accepted
2015-06-30 19:05:23
Documents
3
Period of Report
2015-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1501532_8k.htm 8-K 18899
2 EXHIBIT 3.1 t1501532_ex3-1.htm EX-3.1 23926
3 EXHIBIT 3.2 t1501532_ex3-2.htm EX-3.2 101999
  Complete submission text file 0001571049-15-005411.txt   146143
Mailing Address 1801 CENTURY PARK EAST, SUITE 1820 LOS ANGELES CA 90067
Business Address 1801 CENTURY PARK EAST, SUITE 1820 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 15962763
SIC: 2834 Pharmaceutical Preparations